Schedule of intangibles |
Intangibles, net, consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2020 | (in thousands) | Amortization Method | | Cost | | Accumulated Amortization | | Net | Trademarks | Straight-Line | | $ | 13,540 | | | $ | (10,958) | | | $ | 2,582 | | Customer relationships | Accelerated | | 96,865 | | | (93,770) | | | 3,095 | | Currently marketed product | Straight-Line | | 142,900 | | | (5,053) | | | 137,847 | | Licenses | Straight-Line | | 85,800 | | | (4,008) | | | 81,792 | | Developed technology | Straight-Line | | 2,400 | | | (144) | | | 2,256 | | IPR&D | N/A | | 148,440 | | | — | | | 148,440 | | Total | | | $ | 489,945 | | | $ | (113,933) | | | $ | 376,012 | |
| | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2019 | (in thousands) | Amortization Method | | Cost | | Accumulated Amortization | | Net | Trademarks | Straight-Line | | $ | 13,540 | | | $ | (10,407) | | | $ | 3,133 | | Customer relationships | Accelerated | | 99,019 | | | (94,816) | | | 4,203 | | | | | | | | | | Total | | | $ | 112,559 | | | $ | (105,223) | | | $ | 7,336 | |
|
Schedule of expected future amortization expense |
The below table summarizes the estimated aggregate amortization expense expected to be recognized on the above intangible assets: | | | | | | (in thousands) | Amount | 2021 | $ | 18,628 | | 2022 | 18,504 | | 2023 | 17,898 | | 2024 | 17,824 | | 2025 | 17,766 | | 2026 and thereafter | 136,952 | | Total | $ | 227,572 | |
|
Schedule of goodwill |
Goodwill by reportable segment consisted of the following:
| | | | | | | | | | | | (in thousands) | U.S. | | Total | Balance, January 1, 2020 | $ | 15,714 | | | $ | 15,714 | | Acquisition(1) | 42,918 | | | 42,918 | | Balance, December 31, 2020 | $ | 58,632 | | | $ | 58,632 | |
(1)Refer to Note 8, “Business Combinations” for additional details related to the Progenics acquisition
|